InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Elanco Animal Health Inc

ELAN Clue Score46
United States Fiscal year ends December CIK 0001739104
$22.92 +1.69% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $22.92 −30.31% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 20 Sep 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2016Revenue2.91Net income−0.05Fiscal year 2017Revenue2.89 −0.8%Net income−0.31EPS, diluted−1.06Fiscal year 2018Revenue3.07 +6.2%Net income0.09EPS, diluted0.28Fiscal year 2019Revenue3.07 +0.1%Net income0.07 −21.4%EPS, diluted0.18 −35.7%Fiscal year 2020Revenue3.27 +6.6%Net income−0.57 −944.1%EPS, diluted−1.30 −822.2%Fiscal year 2021Revenue4.76 +45.6%Net income−0.48EPS, diluted−0.99Fiscal year 2022Revenue4.41 −7.4%Net income−0.08EPS, diluted−0.16Fiscal year 2023Revenue4.42 +0.1%Net income−1.23EPS, diluted−2.50Fiscal year 2024Revenue4.44 +0.5%Net income0.34EPS, diluted0.68Fiscal year 2025Revenue4.72 +6.2%Net income−0.23 −168.6%EPS, diluted−0.47 −169.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 2.91 2.89 3.07 3.07 3.27 4.76 4.41 4.42 4.44 4.72
Growth −0.8% +6.2% +0.1% +6.6% +45.6% −7.4% +0.1% +0.5% +6.2%
Net income −0.05 −0.31 0.09 0.07 −0.57 −0.48 −0.08 −1.23 0.34 −0.23
Growth −21.4% −944.1% −168.6%
EPS, diluted n/a −1.06 0.28 0.18 −1.30 −0.99 −0.16 −2.50 0.68 −0.47
Growth −35.7% −822.2% −169.1%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginNet margin
Fiscal year 2016Net margin−1.6%Free cash flow margin1.6%Fiscal year 2017Net margin−10.8%Free cash flow margin2.6%Fiscal year 2018Net margin2.8%Free cash flow margin11.5%Fiscal year 2019Net margin2.2%Free cash flow margin2.7%Fiscal year 2020Net margin−17.5%Free cash flow margin−5.4%Fiscal year 2021Net margin−10.1%Free cash flow margin6.8%Fiscal year 2022Net margin−1.8%Free cash flow margin6.4%Fiscal year 2023Gross margin56.3%Net margin−27.9%Free cash flow margin3.0%Fiscal year 2024Gross margin54.9%Net margin7.6%Free cash flow margin8.9%Fiscal year 2025Gross margin55.0%Net margin−4.9%Free cash flow margin6.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a n/a n/a n/a 56.3% 54.9% 55.0%
Net margin −1.6% −10.8% 2.8% 2.2% −17.5% −10.1% −1.8% −27.9% 7.6% −4.9%
Free cash flow margin 1.6% 2.6% 11.5% 2.7% −5.4% 6.8% 6.4% 3.0% 8.9% 6.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow0.16Capital expenditure−0.11Free cash flow0.05Fiscal year 2017Operating cash flow0.17Capital expenditure−0.10Free cash flow0.08 +64.9%Fiscal year 2018Operating cash flow0.49Capital expenditure−0.13Free cash flow0.35 +369.1%Fiscal year 2019Operating cash flow0.22Capital expenditure−0.14Free cash flow0.08 −76.2%Fiscal year 2020Operating cash flow−0.04Capital expenditure−0.14Free cash flow−0.18 −309.5%Fiscal year 2021Operating cash flow0.48Capital expenditure−0.16Free cash flow0.32Fiscal year 2022Operating cash flow0.45Capital expenditure−0.17Free cash flow0.28 −13.3%Fiscal year 2023Operating cash flow0.27Capital expenditure−0.14Free cash flow0.13 −53.4%Fiscal year 2024Operating cash flow0.54Capital expenditure−0.15Free cash flow0.39 +200.8%Fiscal year 2025Operating cash flow0.56Capital expenditure−0.28Free cash flow0.28 −27.9%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 0.16 0.17 0.49 0.22 −0.04 0.48 0.45 0.27 0.54 0.56
Capital expenditure −0.11 −0.10 −0.13 −0.14 −0.14 −0.16 −0.17 −0.14 −0.15 −0.28
Free cash flow 0.05 0.08 0.35 0.08 −0.18 0.32 0.28 0.13 0.39 0.28
Growth +64.9% +369.1% −76.2% −309.5% −13.3% −53.4% +200.8% −27.9%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.26Shareholders’ equity7.02Fiscal year 2017Cash0.32Total debt0.00Net cash (debt)0.32Shareholders’ equity7.78Debt to equity0.00Fiscal year 2018Cash0.47Total debt2.47Net cash (debt)−2.00Shareholders’ equity5.20Debt to equity0.48Fiscal year 2019Cash0.33Total debt2.36Net cash (debt)−2.02Shareholders’ equity5.54Debt to equity0.42Fiscal year 2020Cash0.50Total debt6.13Net cash (debt)−5.63Shareholders’ equity8.46Debt to equity0.72Fiscal year 2021Cash0.64Total debt6.32Net cash (debt)−5.68Shareholders’ equity7.51Debt to equity0.84Fiscal year 2022Cash0.35Total debt5.84Net cash (debt)−5.49Shareholders’ equity7.29Debt to equity0.80Fiscal year 2023Cash0.35Total debt5.77Net cash (debt)−5.42Shareholders’ equity6.22Debt to equity0.93Fiscal year 2024Cash0.47Total debt4.32Net cash (debt)−3.85Shareholders’ equity6.10Debt to equity0.71Fiscal year 2025Cash0.55Total debt3.76Net cash (debt)−3.22Shareholders’ equity6.55Debt to equity0.57
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.26 0.32 0.47 0.33 0.50 0.64 0.35 0.35 0.47 0.55
Total debt n/a 0.00 2.47 2.36 6.13 6.32 5.84 5.77 4.32 3.76
Net cash (debt) n/a 0.32 −2.00 −2.02 −5.63 −5.68 −5.49 −5.42 −3.85 −3.22
Shareholders’ equity 7.02 7.78 5.20 5.54 8.46 7.51 7.29 6.22 6.10 6.55
Debt to equity n/a 0.00 0.48 0.42 0.72 0.84 0.80 0.93 0.71 0.57

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
2.91 2.89 3.07 3.07 3.27 4.76 4.41 4.42 4.44 4.72
Growth −0.8% +6.2% +0.1% +6.6% +45.6% −7.4% +0.1% +0.5% +6.2%
1.41 1.49 1.57 1.47 1.67 2.13 1.91 1.93 2.00 2.12
n/a n/a n/a n/a n/a n/a n/a 2.49 2.44 2.59
Growth −2.0% +6.4%
0.27 0.25 0.25 0.27 0.33 0.37 0.32 0.33 0.34 0.37
0.78 0.78 0.74 0.76 1.00 1.40 1.27 1.29 1.31 1.43
−0.02 −0.23 0.11 0.08 −0.68 −0.57 −0.07 −1.20 0.49 −0.22
0.03 0.08 0.03 0.01 −0.10 −0.09 0.01 0.04 0.15 0.01
−0.05 −0.31 0.09 0.07 −0.57 −0.48 −0.08 −1.23 0.34 −0.23
Growth −21.4% −944.1% −168.6%
Per share
n/a −1.06 0.28 0.18 −1.30 −0.99 −0.16 −2.50 0.68 −0.47
n/a −1.06 0.28 0.18 −1.30 −0.99 −0.16 −2.50 0.68 −0.47
Growth −35.7% −822.2% −169.1%
293.3 293.3 313.7 369.0 441.4 487.2 488.3 492.3 494.0 496.4
n/a 293.3 313.7 370.3 441.4 487.2 488.3 492.3 497.3 496.4
Growth +7.0% +18.0% +19.2% +10.4% +0.2% +0.8% +1.0% −0.2%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 7.6% a year over five years.
  • The diluted share count rose 12.5% in five years, which is dilution.
  • A net loss in 7 of 10 years on file.